APUS
Apimeds Pharmaceuticals US Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.62
+0.21 ▲ +14.89%
🌙 3월 13일 7:50 PM ET (한국 3/14 08:50)
$1.61
-0.01 ▼ -0.56%
| Index | - | P/E | - | EPS (ttm) | -0.43 | Insider Own | 75.44% | Shs Outstand | 0.01B | Perf Week | 21.8% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | 11.72% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 3.15% | Short Float | 5.03% | Perf Quarter | -22.86% |
| Income | -0.01B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 1.07 | Perf Half Y | -16.49% |
| Sales | 0.00B | P/B | 2.5 | EPS next 5Y | - | ROA | -111.07% | Short Interest | 0.16M | Perf YTD | -1.22% |
| Book/sh | 0.65 | P/C | 2.91 | EPS past 3/5Y | -50.14% - | ROE | -144.99% | 52W High | -59.81% ($4.03) | Perf Year | - |
| Cash/sh | 0.56 | P/FCF | - | Sales past 3/5Y | - | ROIC | -63.2% | 52W Low | 70.35% ($0.95) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -232.48% | Gross Margin | - | Volatility(W/M) | 10.77% 14.21% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.18 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.34 | EPS Q/Q | -440.46% | Profit Margin | - | RSI (14) | 58.23 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.34 | Sales Q/Q | - | SMA20 | 20.63% ($1.34) | Beta | - | Target Price | - |
| Payout | - | Debt/Eq | 0.06 | Earnings | - | SMA50 | 3.4% ($1.57) | Rel Volume | 0.86 | Prev Close | $1.41 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -13.12% ($1.86) | Avg Volume(3M) | 0.14M | Price | $1.62 |
| IPO | 2025/5/9 | Option/Short | No/Yes | Trades | 473 | Volume | 124,828 | Change | 14.89% |
뉴스 로딩 중...